Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Trillium Therapeutics Inc.
T.TRIL
Healthcare
Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TRIL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Comment by
zalmonella
on Dec 15, 2017 2:59pm
RE:The horrible math
Not to worry, the'llk be back. That news last week wasn't "news" - it was simply inviting peers to review its work - a necessary eviil in which there is only downside.
...more
(240)
•••
HuntNGather
X
View Profile
View Bullboard History
Post by
HuntNGather
on Dec 14, 2017 3:15pm
The horrible math
Another fall of 33% in a short span because of (actually pretty damn good) news. Foolish. Now we need a 50% increase to recover that walkback. There is so much institutional money out there on this
...more
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m
posted Nov 13, 2024 9:00am by
Freegold Ventures Limited
-
|
Four specific holes were drilled to facilitate additional metallurgical testing and were strategically designed to collect representative material from the deposit while improving infill drilling efforts. Approximately ~2,400 meters of ½ PQ core (~ 20 tonnes) have been shipped to BaseMet Labs in Kamloops, BC, where a comprehensive suite of metallurgical testing is currently underway ...read more
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Post by
zalmonella
on Dec 13, 2017 12:37pm
Back, to $10 for a while....
A poster a while back, not sure who, made a good case for $10 fair value as a result of this "news". Pumpers like Evel Knievel thought nonsense - "to da moon!" So I
...more
(0)
•••
PoorOpinion
X
View Profile
View Bullboard History
Comment by
PoorOpinion
on Dec 11, 2017 3:51pm
RE:RE:RE:News
When I read it what stood out as a possible negative was the response in the intravenous group. 5 out of 18 with an "objective response" sounded a little low (and vague). But honestly I dont
...more
(4)
•••
thesheet
X
View Profile
View Bullboard History
Comment by
thesheet
on Dec 11, 2017 3:31pm
RE:RE:News
sounds like good news to me,(and the patients). more patience is required on the sell on the news
(0)
•••
SOX2STOX
X
View Profile
View Bullboard History
Comment by
SOX2STOX
on Dec 11, 2017 9:06am
RE:News
https://trilliumtherapeutics.com/investors/news/Press-Release-Details/2017/Trillium-Therapeutics-Provides-Update-on-Its-TTI-621-Program-at-the-American-Society-of-Hematology-59th-Annual-Meeting
...more
(0)
•••
HeyBlinkin
X
View Profile
View Bullboard History
Post by
HeyBlinkin
on Dec 11, 2017 8:13am
News
News from Trillium at ASH
(10)
•••
pfm1998
X
View Profile
View Bullboard History
Post by
pfm1998
on Nov 30, 2017 12:59pm
Yawner on a +350 day on the dow....
(0)
•••
PoorOpinion
X
View Profile
View Bullboard History
Comment by
PoorOpinion
on Nov 28, 2017 7:47pm
RE:What happened today?
The ASH2017 data is embargoed until Dec11th (date of presentation). I was hoping general positive days up until then, this may be a (big) blip but IDK. This stock seems to have the ability to move on
...more
(10)
•••
pfm1998
X
View Profile
View Bullboard History
Post by
pfm1998
on Nov 28, 2017 4:14pm
What happened today?
Big ouch day! -10%. I know it's done great...will it continue higher?
(0)
•••
PoorOpinion
X
View Profile
View Bullboard History
Comment by
PoorOpinion
on Nov 22, 2017 11:04am
RE:Todays news
US volume and continued optimism in the run up to ASH 2017
(0)
•••
PoorOpinion
X
View Profile
View Bullboard History
Post by
PoorOpinion
on Nov 13, 2017 12:08pm
Todays news
continues the run of great clinical data, with a little teaser about what to expect at ASH 17
(0)
•••
Pitvanpout99
X
View Profile
View Bullboard History
Post by
Pitvanpout99
on Nov 06, 2017 8:19am
TRILLIUM THERAPEUTICS TO PRESENT AT UPCOMING SCIENTIFIC CONF
Toronto, Nov. 6, 2017 – Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL) a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that the
...more
(0)
•••
Baylor1965
X
View Profile
View Bullboard History
Comment by
Baylor1965
on Nov 02, 2017 7:47pm
RE:RE:RE:RE:RE:RE:RE:Latest run up...
I think that’s about right for a single IP. That said, IP is low on the big pharma front and a company like tril, which is an IP bank, could be compensated in a big way for the whole company
(0)
•••
Njdevilsfan
X
View Profile
View Bullboard History
Comment by
Njdevilsfan
on Nov 01, 2017 5:16pm
RE:RE:RE:RE:RE:RE:Latest run up...
i really wouldn't know, maybe $50+ million upfront, a few hundred million after successful trials and royalties?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.